PLA2G16 specifically catalyzes the release of fatty acids from phospholipids in adipose tissue. It also has a weak lysophospholipase activity. Tumor suppressor that may be involved in interferon-dependent cell death.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Adipose-specific phospholipase A2; adipose-specific PLA2; AdPLA; Ca-independent phospholipase A1/2; Group XVI phospholipase A1/A2; group XVI phospholipase A2; H-rev 107 protein homolog; H-REV107; H-REV107-1; HRAS-like suppressor 1; HRAS-like suppressor 3; HRASLS3; HREV107; HREV107-1; HREV107-3; HRSL3; phospholipase A2, group XVI; Renal carcinoma antigen NY-REN-65
Gene Aliases: AdPLA; H-REV107-1; HRASLS3; HREV107; HREV107-1; HREV107-3; HRSL3; PLA2G16
UniProt ID: (Human) P53816
Entrez Gene ID: (Human) 11145